| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| R C Eastman, R F Arakaki, T Shawker, R Schock, P Roach, R J Comi, P Gorde. A prospective examination of octreotide-induced gall-bladder changes in acromegaly. Clinical endocrinology. vol 36. issue 3. 1992-05-21. PMID:1563079. |
we wished to determine the effects of octreotide acetate, a somatostatin analogue, on gall-bladder function during treatment of acromegaly. |
1992-05-21 |
2023-08-11 |
Not clear |
| K K Ho, A B Jenkins, S M Furler, M Borkman, D J Chishol. Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clinical endocrinology. vol 36. issue 3. 1992-05-21. PMID:1563080. |
impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. |
1992-05-21 |
2023-08-11 |
Not clear |
| K K Ho, A B Jenkins, S M Furler, M Borkman, D J Chishol. Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly. Clinical endocrinology. vol 36. issue 3. 1992-05-21. PMID:1563080. |
we aimed to investigate the impact of a long-acting somatostatin analogue, octreotide, on glucose tolerance and on insulin sensitivity in acromegaly. |
1992-05-21 |
2023-08-11 |
Not clear |
| N R Musolino, R Marino Júnior, M D Bronstei. Headache in acromegaly: dramatic improvement with the somatostatin analogue SMS 201-995. The Clinical journal of pain. vol 6. issue 3. 1992-05-19. PMID:2135020. |
headache in acromegaly: dramatic improvement with the somatostatin analogue sms 201-995. |
1992-05-19 |
2023-08-11 |
Not clear |
| W Saege. Effect of drugs on pituitary ultrastructure. Microscopy research and technique. vol 20. issue 2. 1992-04-23. PMID:1547357. |
dopamine agonists and somatostatin reduce the tumor size of varying proportions of gh secreting adenomas in acromegaly. |
1992-04-23 |
2023-08-11 |
human |
| Julio Pascual, Julio Freijanes, José Berciano, Carlos Pesquer. Analgesic effect of octreotide in headache associated with acromegaly is not mediated by opioid mechanisms. Case report. Pain. vol 47. issue 3. 1992-03-19. PMID:1664509. |
we report a patient with acromegaly who had severe, intractable headache unrelated to tumor size which dramatically resolved with the somatostatin analog octreotide. |
1992-03-19 |
2023-08-11 |
Not clear |
| X F Zhu, Y F Shi, J X Zhan. [Prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue SMS201-995 in patients of active acromegaly]. Zhonghua nei ke za zhi. vol 30. issue 7. 1992-01-27. PMID:1752152. |
[prospective study of functional changes in the gallbladder and formation of gallstones induced by long-term treatment of somatostatin analogue sms201-995 in patients of active acromegaly]. |
1992-01-27 |
2023-08-11 |
Not clear |
| R A James, N Møller, S Chatterjee, M White, P Kendall-Taylo. Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide. Diabetic medicine : a journal of the British Diabetic Association. vol 8. issue 6. 1991-10-17. PMID:1832350. |
carbohydrate tolerance and serum lipids were studied in 14 patients with acromegaly before and in response to treatment with high dose somatostatin analogue (octreotide) over a 14-week period. |
1991-10-17 |
2023-08-11 |
Not clear |
| S Ezzat, S G Ren, G D Braunstein, S Melme. Octreotide stimulates insulin-like growth factor binding protein-1 (IGFBP-1) levels in acromegaly. The Journal of clinical endocrinology and metabolism. vol 73. issue 2. 1991-08-27. PMID:1713220. |
the somatostatin analogue, octreotide, has been used to effectively control hypersomaototropism in acromegaly. |
1991-08-27 |
2023-08-11 |
Not clear |
| H Orskov, S E Christensen, J Weeke, A Kaal, A G Harri. Effects of antibodies against octreotide in two patients with acromegaly. Clinical endocrinology. vol 34. issue 5. 1991-08-08. PMID:2060149. |
two patients developed specific igg antibodies against octreotide after 2-3 years' treatment for acromegaly with this long acting somatostatin analogue. |
1991-08-08 |
2023-08-11 |
Not clear |
| E Lund, J Jørgensen, S E Christensen, J Weeke, H Orskov, A G Harri. Reduction in sella turcica volume. An effect of long-term treatment with the somatostatin analogue, SMS 201-995, in acromegalic patients. Neuroradiology. vol 33. issue 2. 1991-07-17. PMID:2046904. |
ten patients with acromegaly were treated with the long-acting somatostatin analogue, sandostatin (sms 201-995, octreotide) for more than one year. |
1991-07-17 |
2023-08-11 |
Not clear |
| J A McKnight, D R McCance, B Sheridan, E McIlrath, D R Hadden, L Kennedy, A B Atkinso. A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegaly. Clinical endocrinology. vol 34. issue 2. 1991-06-06. PMID:1902408. |
a long-term dose-response study of somatostatin analogue (sms 201-995, octreotide) in resistant acromegaly. |
1991-06-06 |
2023-08-11 |
human |
| J A McKnight, D R McCance, B Sheridan, E McIlrath, D R Hadden, L Kennedy, A B Atkinso. A long-term dose-response study of somatostatin analogue (SMS 201-995, octreotide) in resistant acromegaly. Clinical endocrinology. vol 34. issue 2. 1991-06-06. PMID:1902408. |
ten acromegalic subjects were studied in a trial designed to ascertain the optimum dosage of the somatostatin analogue sms 201-995 (octreotide) in active acromegaly. |
1991-06-06 |
2023-08-11 |
human |
| C J Choi, D B Shin, S W Kim, I M Yang, J W Kim, Y S Kim, Y K Cho. The effect of long acting somatostatin analogue SMS 201-995 in acromegaly. The Korean journal of internal medicine. vol 2. issue 2. 1991-05-23. PMID:3155325. |
the effect of long acting somatostatin analogue sms 201-995 in acromegaly. |
1991-05-23 |
2023-08-11 |
Not clear |
| K Schmidt, P H Althoff, A Harris, W Hofmeister-Wagner, E Schifferdecker, K Schöfflin. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests]. Medizinische Klinik (Munich, Germany : 1983). vol 85. issue 12. 1991-05-17. PMID:2128367. |
[long-term treatment of acromegaly with the somatostatin analog octreotide (sandostatin). |
1991-05-17 |
2023-08-11 |
Not clear |
| A Liuzzi, D Dallabonzana, G Oppizzi, R Cozzi, P G Chiodin. [Medical treatment of acromegaly with dopaminergic agents]. Minerva endocrinologica. vol 15. issue 1. 1991-02-28. PMID:1980333. |
currently octractide, a long lasting somatostatin analogue, is the most effective drug in the medical treatment of acromegaly; however the dopaminergic agonists remain a valid alternative. |
1991-02-28 |
2023-08-11 |
Not clear |
| R Abs, A Beckers, F L Van de Vyver, A De Schepper, A Stevenaert, G Henne. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia. A variant of the McCune-Albright syndrome. Journal of endocrinological investigation. vol 13. issue 8. 1991-02-28. PMID:2273209. |
treatment of the acromegaly with the long-acting somatostatin analogue octreotide resulted in an important inhibition of the gh secretion and in a reduction of the volume of the pituitary adenoma. |
1991-02-28 |
2023-08-11 |
Not clear |
| R Attanasio, P G Chiodini, A Liuzzi, P Orlandi, C De Palo, D Dallabonzana, A Lodrini, R Cozz. Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly. Journal of endocrinological investigation. vol 13. issue 8. 1991-02-28. PMID:2273211. |
resistance to a long-acting somatostatin analog (sms 201-995) reversed by surgery in acromegaly. |
1991-02-28 |
2023-08-11 |
Not clear |
| M Arosio, N Bazzoni, G Fagli. [Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action]. Minerva endocrinologica. vol 15. issue 1. 1991-02-28. PMID:2274011. |
[treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action]. |
1991-02-28 |
2023-08-11 |
Not clear |
| N Sicolo, C Martini, S Ferla, J Roggenkamp, R Vettor, C De Palo, G Federspi. [Analgesic effect of Sandostatin (SMS 201-995) in acromegaly headache]. Minerva endocrinologica. vol 15. issue 1. 1991-02-28. PMID:2274013. |
somatostatin analogue (sandostatin; sms 201-995) is utilized as a therapy in acromegaly because of its efficiency in inhibiting gh secretion; it induces some clinical improvements, such as headache remission in acromegalic patient, which seem to be unrelated to gh normalization. |
1991-02-28 |
2023-08-11 |
Not clear |